Health Board Suspends Use of Pandemrix Vaccine

Photo: AFP/Scanpix
2/2/2011 3:07 PM
Category: News

The chief public health authority has suspended the use of the H1N1 flu vaccine Pandemrix, now believed to be related to cases of narcolepsy across Europe.

According to the State Agency of Medicines website, researchers now consider it probable that use of Pandemrix combined with some yet unidentified factors has caused a heightened incidence of narcolepsy in Finland.

In Estonia, use of Pandemrix has been less widespread than in other European countries, Maia Uusküla, drug safety director of the State Agency of Medicines, told ETV. According to her, there have been few reports of serious side effects. The two more serious cases have been allergy-related.

As of February 1, 10,300 people in Estonia had been vaccinated with Pandemrix.


The name field cannot be empty
No more than 50 characters
Comment field cannot be empty
No more than 50 characters
Comment field cannot be empty
No more than 1024 characters
{{error}}

Message forwarded to the editor

This Ip-address has limited access

See also

There are no comments yet. Be the first!

Reply to comment

+{{childComment.ReplyToName}}:
Reply to comment
Reply

Laadi juurde ({{take2}})
The name field cannot be empty
No more than 50 characters
Comment field cannot be empty
No more than 1024 characters
{{error}}
Add new comment